STAMOS CAPITAL PARTNERS, L.P.
STAMOS CAPITAL PARTNERS, L.P. is a Series C+ and buyout fund in the US investing in Healthcare, biotechnology, medical and medical-device.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, biotechnology, medical, medical-device
- Invests in
- US-wide
- Founded
- 2002
- Assets under management
- $7.6B
- Website
- stamoscapital.com
Check size not disclosed
Thesis
Stamos Capital Partners is an independent investment advisory firm founded in 2002, headquartered in Menlo Park, California. The firm manages over $7.6 billion in assets (as of December 2025). Stamos employs an endowment-style investment approach, investing across traditional and alternative asset classes. The firm favors a flexible investment mandate with asset allocation across multiple asset classes, including fixed-income, public equity, private equity, and real assets. Investment decisions are driven by macroeconomic views, asset allocation analyses, investment access, risk management assessments, and differing investment horizons. The firm allocates assets across two major categories: Capital Preservation and Capital Appreciation, investing directly or through Underlying Managers.
Common questions
Does STAMOS CAPITAL PARTNERS, L.P. invest at the Series C+ stage?
Yes. STAMOS CAPITAL PARTNERS, L.P. lists Series C+ and buyout among the stages it invests in.
Where does STAMOS CAPITAL PARTNERS, L.P. invest?
STAMOS CAPITAL PARTNERS, L.P. invests in the US.